Our mission
Our mission is to help biopharmaceutical and medical device companies improve patient outcomes as they introduce therapies to market.
Our core values
At ACTO, we work together to serve our customers and the industry following five guiding principles.
Be the painkiller.
We consistently strive to solve the problems of our customers, and the Life Sciences industry at large.
Change lives.
We are driven by the desire to make a real impact on people and change lives, at scale.
Bend the spoon.
We challenge the status quo with creativity and resourcefulness, while executing with tenacity and intent.
Be human.
We recognize that no matter the circumstances, our approach is always human as we drive results.
Act today.
The ACTO name was derived from “act today” - we always act with urgency, purpose, and intent.
Our leadership
We are a purpose-driven team with a bold vision and the courage to make a positive impact in the world.
Read our story
Recognized for excellence
We are proud to be recognized for excellence in technology, innovation, and leadership.
PEAK Matrix ®
Major Contender2023
Pharma Tech Outlook
Top Veeva Solutions Provider2023
Great Places To Work
Great Places To Work Certified2023
Everest Group
Trailblazers2022
Great Place To Work
Great Places To Work Certified2022
Great Place To Work
Great Places To Work Certified2021
Maple Leaf Angels
Company of the Year2020
Stevie Award Silver
Sales & Customer Service2020
Timmy Award
Regional Winner, Best Tech for Good2020
LTEN Excellence Awards
Industry Partnership Winner2020
Great Places To Work
Best Workplace for Start-Ups in Canada2020
Stevie Award Gold
Cloud Platform category2019
Brandon Hall Silver
Excellence in Technology2019
Brandon Hall Bronze
Excellence in Learning2019
LTEN Excellence Awards
Innovation Finalist2019
PM360 Elite 100
Entrepreneurs2019
Our partners
ACTO partners with leading technology, content, and service providers to ensure a seamless, integrated, and simple experience for your learners.
Our investors
ACTO is honored to have the support of our investors.